603 related articles for article (PubMed ID: 16596586)
21. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxicity of Paclitaxel in biodegradable self-assembled core-shell poly(lactide-co-glycolide ethylene oxide fumarate) nanoparticles.
He X; Ma J; Mercado AE; Xu W; Jabbari E
Pharm Res; 2008 Jul; 25(7):1552-62. PubMed ID: 18196205
[TBL] [Abstract][Full Text] [Related]
23. Toward immunosuppressive effects on liver transplantation in rat model: tacrolimus loaded poly(ethylene glycol)-poly(D,L-lactide) nanoparticle with longer survival time.
Xu W; Ling P; Zhang T
Int J Pharm; 2014 Jan; 460(1-2):173-80. PubMed ID: 24172796
[TBL] [Abstract][Full Text] [Related]
24. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation.
Jiang X; Xin H; Sha X; Gu J; Jiang Y; Law K; Chen Y; Chen L; Wang X; Fang X
Int J Pharm; 2011 Nov; 420(2):385-94. PubMed ID: 21920419
[TBL] [Abstract][Full Text] [Related]
25. Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery.
Song N; Liu W; Tu Q; Liu R; Zhang Y; Wang J
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):454-63. PubMed ID: 21719259
[TBL] [Abstract][Full Text] [Related]
26. Amphiphilic block copolymer NPs obtained by coupling ricinoleic acid/sebacic acids and mPEG: Synthesis, characterization, and controlled release of paclitaxel.
Zhou S; Sun W; Zhai Y
J Biomater Sci Polym Ed; 2018 Dec; 29(18):2201-2217. PubMed ID: 30285542
[TBL] [Abstract][Full Text] [Related]
27. Preparation of nanoparticles consisted of poly(L-lactide)-poly(ethylene glycol)-poly(L-lactide) and their evaluation in vitro.
Matsumoto J; Nakada Y; Sakurai K; Nakamura T; Takahashi Y
Int J Pharm; 1999 Aug; 185(1):93-101. PubMed ID: 10425369
[TBL] [Abstract][Full Text] [Related]
28. Nanoparticles of biodegradable polymers for clinical administration of paclitaxel.
Feng SS; Mu L; Win KY; Huang G
Curr Med Chem; 2004 Feb; 11(4):413-24. PubMed ID: 14965222
[TBL] [Abstract][Full Text] [Related]
29. Development of chlorin e6-conjugated poly(ethylene glycol)-poly(d,l-lactide) nanoparticles for photodynamic therapy.
Kumari P; Rompicharla SVK; Bhatt H; Ghosh B; Biswas S
Nanomedicine (Lond); 2019 Apr; 14(7):819-834. PubMed ID: 30874479
[TBL] [Abstract][Full Text] [Related]
30. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS.
Mu L; Feng SS
J Control Release; 2003 Jan; 86(1):33-48. PubMed ID: 12490371
[TBL] [Abstract][Full Text] [Related]
31. Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer.
Lv W; Cheng L; Li B
Chem Pharm Bull (Tokyo); 2015; 63(2):68-74. PubMed ID: 25451039
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and characterization of a novel polydepsipeptide contained tri-block copolymer (mPEG-PLLA-PMMD) as self-assembly micelle delivery system for paclitaxel.
Zhao Y; Li J; Yu H; Wang G; Liu W
Int J Pharm; 2012 Jul; 430(1-2):282-91. PubMed ID: 22484705
[TBL] [Abstract][Full Text] [Related]
33. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.
Xin H; Chen L; Gu J; Ren X; Wei Z; Luo J; Chen Y; Jiang X; Sha X; Fang X
Int J Pharm; 2010 Dec; 402(1-2):238-47. PubMed ID: 20934500
[TBL] [Abstract][Full Text] [Related]
34. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
35. Development of a novel biocompatible poly(ethylene glycol)-block-poly(γ-cholesterol-L-glutamate) as hydrophobic drug carrier.
Ma Q; Li B; Yu Y; Zhang Y; Wu Y; Ren W; Zheng Y; He J; Xie Y; Song X; He G
Int J Pharm; 2013 Mar; 445(1-2):88-92. PubMed ID: 23376505
[TBL] [Abstract][Full Text] [Related]
36. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
37. Polymer-polymer conjugation to fabricate multi-block polymer as novel drug carriers: poly(lactic acid)-poly(ethylene glycol)-poly(L-lysine) to enhance paclitaxel target delivery.
Liu Y; Liu C; Li M; Liu F; Feng L; Zhang L; Zhang N
J Biomed Nanotechnol; 2014 Jun; 10(6):948-58. PubMed ID: 24749390
[TBL] [Abstract][Full Text] [Related]
38. Preparation and characterization of biodegradable poly(l-lactide)/poly(ethylene glycol) microcapsules containing erythromycin by emulsion solvent evaporation technique.
Park SJ; Kim SH
J Colloid Interface Sci; 2004 Mar; 271(2):336-41. PubMed ID: 14972610
[TBL] [Abstract][Full Text] [Related]
39. Polymeric micelles and nanoemulsions as drug carriers: Therapeutic efficacy, toxicity, and drug resistance.
Gupta R; Shea J; Scafe C; Shurlygina A; Rapoport N
J Control Release; 2015 Aug; 212():70-7. PubMed ID: 26091919
[TBL] [Abstract][Full Text] [Related]
40. Preparation of biodegradable nanoparticles of tri-block PLA-PEG-PLA copolymer and determination of factors controlling the particle size using artificial neural network.
Asadi H; Rostamizadeh K; Salari D; Hamidi M
J Microencapsul; 2011; 28(5):406-16. PubMed ID: 21736525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]